TECHNOLOGYAlphabet-Owned Firm to Begin Human Trials for AI-Developed Cancer DrugDhruva KulkarniJuly 8, 2025July 8, 2025 July 8, 2025July 8, 2025 Isomorphic Labs, a pharmaceutical company owned by Alphabet, is preparing to begin human trials for its cancer drug, developed using AlphaFold 3, an advanced AI...